One year after product launch, pharmaceutical companies have accumulated an abundance of sales-related data. Commercial operations teams can use this data to conduct advanced analytics, identify new targets and transition to a more sustainable incentive compensation plan. Associate Partner Melissa McDevitt shares with PharmaLive how pharmaceutical companies should embrace their sales data to discover new insights and maximize sales beyond the one-year mark.